Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with an unknown etiology and currently few effective therapies. Immune system alterations have being demonstrated in ASD, both in humans and via animal models; immune imbalance thus arises as a possible pathway for drug intervention. In this review, the studies were classified into 2 major groups: (1) clinical research whose authors classify therapies with primary anti-inflammatory and immunomodulatory actions, making use of: sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, flavonoid luteolin, corticosteroids, oral immunoglobulin, intravenous immunoglobulin, cell therapy, dialyzable lymphocyte extracts, minocycline, and pioglitazone; and (2) other ASD therapies already used or currently under study whose initial characteristics were neither anti-inflammatory nor immunomodulatory initially, but displayed a capacity for immunomodulation throughout the treatment: risperidone, vitamin D, omega-3, Ginkgo biloba, L-carnosine, N-acetylcysteine, and microbiome restoration. These studies used various data acquisition methodologies. Questions arose such the need for randomized and placebo-controlled studies with greater numbers of participants as well as the use of biomarkers to refine the treatment of autistic subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, studies in human and animal models indicate immunological dysfunction in ASD (61), while recent research highlights the co-ocurrence of mast cell dysregulation in EDS (62, 63) suggesting problems in the immune system.”
From Autism, joint hypermobility-related disorders and pain (2018) · cites this paper as [61]
Citations
Cites
1 retracted
Items 201–236 of 236
Change in Plasma Cytokine Levels During Risperidone Treatment in Children with Autism
Choi, J. E., Widjaja, F., Careaga, M., Bent, S., Ashwood, P., & Hendren, R. L. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0108 · Cited by 31
Treatment with buspirone in a patient with autism
McCormick, L. H. (1997) · Archives of Family Medicine · doi:10.1001/archfami.6.4.368 · Cited by 31
Buitelaar, J. K., van Engeland, H., de Kogel, K., VRIES, H. D., van Hooff, J. A. R. A. M., & REE, J. V. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00026 · Cited by 30
Tobiasova, Z., van der Lingen, K. H. B., Scahill, L., Leckman, J. F., Zhang, Y., Chae, W., McCracken, J. T., McDougle, C. J., Vitiello, B., Tierney, E., et al. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0134 · Cited by 29
Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitus
Yandrapalli, S., & Aronow, W. S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.70 · Cited by 29
Aldosterone Synthesis and Cytokine Production in Human Peripheral Blood Mononuclear Cells
Miura, R., Nakamura, K., Miura, D., Miura, A., Hisamatsu, K., Kajiya, M., Hashimoto, K., Nagase, S., Morita, H., KUSANO, K. F., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060801 · Cited by 28
Plasma level of transforming growth factor β 1 in children with autism spectrum disorder
Gohary, T. M. E., Aziz, N. A. E., Darweesh, M. E., & Sadaa, E. S. (2014) · Egyptian Journal of Ear Nose Throat and Allied Sciences · doi:10.1016/j.ejenta.2014.12.002 · Cited by 27
Mordekar, S., Prendergast, M., Chattopadhyay, A. K., & Baxter, P. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.06.001 · Cited by 27
Pentoxifylline: Brief Review and Rationale for Its Possible Use in the Treatment of Autism
Gupta, S., Rimland, B., & Shilling, P. D. (1996) · Journal of Child Neurology · doi:10.1177/088307389601100622 · Cited by 27
Niederhofer, H., Staffen, W., & Mair, A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300130 · Cited by 27
Zhang, R., He, G.-Z., Wang, Y.-K., Zhou, K.-G., & Ma, E. (2014) · Nutrition · doi:10.1016/j.nut.2014.10.015 · Cited by 27
N -Acetylcysteine as Treatment for Self-Injurious Behavior in a Child with Autism
Marler, S., Sanders, K. B., & Veenstra-VanderWeele, J. M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0137 · Cited by 24
Niederhofer, H. (2009) · Phytotherapy Research · doi:10.1002/ptr.2778 · Cited by 24
Dialysable leukocyte extracts in immunotherapy
Arnaudov, A., & Kostova, Z. (2015) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2015.1060136 · Cited by 24
Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment
Knabe, R., Schulz, P., & Richard, J. (1990) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02216064 · Cited by 23
Sharma, A. K., & Badhe, P. B. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000139 · Cited by 23
Karapinar, S. P., Akkaya‐Ulum, Y. Z., Özçelik, B., Buzoğlu, H. D., Ceyhan, D., Peynircioğlu, B. B., & Aksoy, Y. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.03.017 · Cited by 22
Kato, Y., Kamiya, H., Koide, N., Odkhuu, E., Komatsu, T., Dagvadorj, J., Watarai, A., Kondo, M., Kato, K., Nakamura, J., et al. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.921690 · Cited by 21
Omega-3 supplementation in autism spectrum disorders: A still open question?
Posar, A., & Visconti, P. (2016) · Journal of Pediatric Neurosciences · doi:10.4103/1817-1745.193363 · Cited by 21
Williams, P. G., Allard, A., Sears, L., Dalrymple, N., & Bloom, A. S. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005674016014 · Cited by 19
A controlled trial with ORG 2766, an ACTH-(4–9) analog, in 50 relatively able children with autism
Buitelaar, J. K., Dekker, M. E. M., van Ree, J. M., & van Engeland, H. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00049-u · Cited by 18
Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats
Jiménez-Pérez, J., Casillas-Ramírez, A., Torres-González, L., Muñoz-Espinosa, L. E., Perales-Quintana, M. M., Galván, G. A., Zapata-Chavira, H. A., Garza, F., Camara-Lemarroy, C. R., Fernández-Garza, N. E., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3196431 · Cited by 17
Naltrexone plasma levels, clinical response and effect on weight in autistic children.
Gonzalez, N. M., Campbell, M., Small, A. M., Shay, J., Bluhm, L. D., Adams, P., & Foltz, R. L. (1994) · PubMed · Cited by 15
Makinodan, M., Iwata, K., Ikawa, D., Yamashita, Y., Yamamuro, K., Toritsuka, M., Kimoto, S., Okumura, K., Yamauchi, T., Yoshino, H., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.005 · Cited by 15
Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism
Chez, M., Low, R., Parise, C., & Donnel, T. (2012) · Autism Research and Treatment · doi:10.1155/2012/291601 · Cited by 14
[Open study of fluoxetine in children with autism].
Pertejo, M. A., Guerra, M. P., & Gilaberte, I. (2000) · Actas Españolas de Psiquiatría · Cited by 13
Bansal, H., Verma, P., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016) · PubMed · Cited by 13
Acetylcysteine for treatment of autism spectrum disorder symptoms
Stutzman, D. L., & Dopheide, J. A. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150072 · Cited by 11
Human Embryonic Stem Cells in the Treatment of Autism: A Case Series.
Shroff, G. (2017) · Europe PMC (PubMed Central) · Cited by 11
Song, R., Yu, D., Yoon, J.-S., & Park, J. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.06.012 · Cited by 10
Complementary and Alternative Medicine in Autism: The Question of Omega-3
Posar, A., & Visconti, P. (2016) · Pediatric Annals · doi:10.3928/00904481-20160129-01 · Cited by 10
Dolatabadi, H. R. D., Zarrindast, M. R., Reisi, P., & Nasehi, M. (2017) · Advanced Biomedical Research · doi:10.4103/abr.abr_49_17 · Cited by 8
A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism
Marchezan, J., Becker, M. M., Schwartsmann, G., Ohlweiler, L., Roesler, R., Renck, L. B., Gonçalves, M. M. M., Ranzan, J., & Riesgo, R. D. S. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000213 · Cited by 7
Self-citationEffects of ORG-2766 on brain event-related potentials of autistic children
Verbaten, M. N., Kemner, C., Buitelaar, J. K., van Ree, J. M., van Beijsterveld, C. E. M., & van Engeland, H. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)89319-x · Cited by 6
SalLam, M., Motaleb, F. I. A., Ahmed, M. A., & Mahmoud, A. (2010) · Egyptian Journal of Biochemistry and Molecular Biology · doi:10.4314/ejbmb.v28i2.60793 · Cited by 4
Rose, D. R., de Water, J. V., & Ashwood, P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.080 · Cited by 2
Cited by
Brain-body interactions underlying the association of loneliness with mental and physical health
Quadt, L., Esposito, G., Critchley, H. D., & Garfinkel, S. N. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.015 · Cited by 137
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 136
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 124
Trzmiel, T., Purandare, B., Michalak, M., Zasadzka, E., & Pawlaczyk, M. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.004 · Cited by 96
Chang, J. P., & Su, K. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.469 · Cited by 82
Metadata
- Authors
- Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 25
- Issue
- 5-6
- Pages
- 300-319
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2892087768
- Cited by
- 70
- References
- 236
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 4 · 2018: 3
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, immune dysfunction, immunomodulatory therapy, anti-inflammatory therapy, sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, luteolin, corticosteroids, intravenous immunoglobulin, oral immunoglobulin, cell therapy, minocycline, pioglitazone, risperidone, vitamin D, omega-3 fatty acids, Ginkgo biloba, L-carnosine, N-acetylcysteine, microbiota restoration, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Animals, Humans, Immunotherapy, Neuroimmunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.